KALAMAZOO–Stryker Corp. (NYSE: SYK), the Kalamazoo-based medical device manufacturer, announced the launch of its Pulse Intelligent Delivery Platform, new technology for high volume foot and ankle procedures in the ambulatory surgery center setting, at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting this week in Québec City, Canada.
The company will also feature its Prophecy Footprint Surgical Planning, which will be the first surgical planning tool to provide clinical guidance on the whole foot in connection with total ankle arthroplasty.
“This is an exciting year for Stryker’s Foot & Ankle business, as we continue to expand our robust portfolio to meet the needs of our surgeon customers,” said Michael Rankin, vice president of marketing and medical education for Stryker’s Foot & Ankle business unit. “With the launch of the Pulse Intelligent Delivery Platform, we now offer a comprehensive suite of products that provides a robust program for foot and ankle surgery within an ASC setting.”
The Pulse Intelligent Delivery Platform provides an integrated product configuration and delivery offering for foot and ankle surgery within the ASC setting of care through:
* Smarter Configurations: Pulse offers a comprehensive suite of surgery-ready forefoot products designed to reduce clutter in the operating room as well as provide ease of use, sterilization processing cost savings and sustainability.
* Personalized Inventory: Pulse’s procedure mapping technology learns from customer preferences and makes inventory recommendations to keep facilities stocked with what they need.
* Automated Service: Radio frequency identification (RFID) technology monitors ASC inventory and triggers replenishment orders automatically, providing peace of mind to ASC stakeholders and surgeons alike.
Also being introduced at AOFAS is Prophecy Footprint, an add-on service to Stryker’s Prophecy Surgical Planning system that provides an understanding of the ancillary procedures to be considered for patients needing total ankle replacement surgery with concomitant pathology. Prophecy Footprint is currently in limited release in the U.S., with plans for a full launch next year.
Rounding out its offering for foot and ankle procedures, Stryker will showcase the CurveBeam AI HiRise weight-bearing computerized tomography imaging system. Stryker’s Foot & Ankle business has entered into an exclusive co-promotion and distribution agreement with CurveBeam AI, a leader in WBCT. This exclusive agreement will offer a turnkey surgical solution for our foot and ankle surgeon customers treating complex deformities.
More at www.stryker.com.